Compound ID | 1916
Class: Beta-lactam (cephalosporin, third generation)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive bacteria and against many Enterobacteriaceae but vulnerable to extended-spectum beta-lactamases (ESBL) |
| Description: | Semisynthetic Cephalosporine (cephem), derived from Cephalosporin C. Oral application. |
| Year first mentioned: | 1997 |
| Highest developmental phase: | Approved in Japan |
| Development status: | Approved |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/Cefcapene |
| Guide to Pharmacology: | cefcapene |
| Citation: | https://journals.sagepub.com/doi/pdf/10.1177/147323000403200604 |